Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert

Arthritis Care and Research

Volumn 61, Issue 11, 2009, Pages 1505-1510

  Ledwich, Lindsay J ^a   Harrington, Thomas M ^a   Ayoub, William T ^a   Sartorius, Jennifer A ^a   Newman, Eric D ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL ORDER; PHYSICIAN; PRACTICE GUIDELINE; REMINDER SYSTEM; REVACCINATION; RHEUMATOID ARTHRITIS; STREPTOCOCCUS PNEUMONIA;

AGED; BENCHMARKING; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; QUALITY OF HEALTH CARE; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 70449513025     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24873     Document Type: Article

References (50)

1. Baum J. Infections in rheumatoid arthritis. Arthritis Rheum 1971;14:135-137
2. Aronoff A, Bywaters DG, Fearnley GR. Lung lesions in rheumatoid arthritis. Brit Med J 1955;2:228-232
3. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-2293
4. Wolfe F, Mitchell DM, Sibley JT, Fries JK, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-494
5. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006;54:628-634 (Pubitemid 43228641)
6. Gluck T, Kiefmann B, Grohmann M, Falk W, Straub RH, Scholmerich J. Immune status and risk of infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 2005;32:1473-1480 (Pubitemid 41113967)
7. Fessler BJ. Infectious disease in systemic lupus erythematosus: risk factors, management, and prophylaxis. Best Pract Res Clin Rheumatol 2002;16:281-291 (Pubitemid 36526644)
8. Boerbooms AM, Kerstens P, van Loenhout JW, Mulder J, van de Putte LB. Infections during low-dose methotrexate treatment in rheumatoid arthritis. Semin Arthritis Rheum 1995;24:411-421
9. Van der Veen MJ, van der Heide A, Kruize AA, Bijlsma JW. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53:224-228 (Pubitemid 24147188)
10. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA 2006;295:2275-2285
11. Centers for Disease Control and Prevention. The immunocompromised traveler: yellow book. 2009. URL: http://wwwn.cdc.gov/travel/yellowBookCh9- Immunocompromised.aspx.
12. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007 - September 2008. Ann Intern Med 2008;147:725-729
13. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2008;150:40-44
14. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-784
15. Avery RK. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 1999;25:568-584
16. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006;355:2513-2522 (Pubitemid 44917499)
17. Spaude KA, Abrutyn E, Kirchner C, Kim A, Daley J, Fisman DN. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med 2007;167:53-59 (Pubitemid 46072407)
18. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community dwelling elderly. N Engl J Med 2007;357:1373-1381 (Pubitemid 47535592)
19. Cornu C, Yzebe D, Leophonte P, Gaillat J, Boissel JP, Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001;19:4780-4790 (Pubitemid 32800764)
20. Posfay-Barbe KM, Wald ER. Pneumococcal vaccines: do they prevent infection and how? Curr Opin Infect Dis 2004;17:177-184
21. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-1775 (Pubitemid 36514705)
22. Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D. Influenza vaccination in patients with rheumatic diseases. JAMA 1979;242:53-56
23. Abu-shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S. Influenza virus vaccination of patients with systemic lupus erythematous: effects on disease activity. J Rheumatol 2000;27:1681-1685 (Pubitemid 30462811)
24. Holvast A, Huckriede A, Wilschut J, Horst G, de Vries JJ, Benne CA, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematous with quiescent disease. Ann Rheum Dis 2006;65:913-918
25. Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007;6:300-305
26. Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauer S, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998;41:1828-1832 (Pubitemid 28465537)
27. Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-153 (Pubitemid 34028344)
28. Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Levartovsky D, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF α blockers. Ann Rheum Dis 2006;65:191-194 (Pubitemid 43131992)
29. Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonnson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006;45:106-111
30. Gelinck LB, Teng YK, Rimmelzwann GF, van den Bemt BJ, Kroon F, van Laar J. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab [letter]. Ann Rheum Dis 2007;66:1402-1403 (Pubitemid 47492493)
31. Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-1361 (Pubitemid 38879202)
32. Jarrett MP, Schiffman G, Barland P, Grayzel AI. Impaired response to pneumococcal vaccine in systemic lupus erythematous. Arthritis Rheum 1980;23:1287-1293 (Pubitemid 11234046)
33. Shapiro E, Clemens J. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med 1984;101:325-330 (Pubitemid 14033779)
34. US Department of Health and Human Services. Healthy people 2010. URL: http://wonder.cdc.gov/data2010/obj.htm.
35. Sowden E, Mitchell W. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007;8:58. (Pubitemid 47252000)
36. Fahy WA, Farnworth E, Yeldrem KP, Melling GS, Grennan DM. Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy [letter]. Rheumatology (Oxford) 2006;45:912-913 (Pubitemid 43985385)
37. Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis [letter]. Ann Rheum Dis 2007;66:837-838 (Pubitemid 46846712)
38. Bridges MJ, Coady D, Kelly CA, Hamilton J, Heycock C. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis [letter]. Ann Rheum Dis 2003;62:685. (Pubitemid 36760575)
39. Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2000;49:15-26.
40. Warner EA, Seleznick MJ. Using medical record reminders to improve pneumococcal vaccination rates. Jt Comm J Qual Saf 2004;30:331-334
41. Nichol KL. Improving influenza vaccination rates among adults. Cleve Clin J Med 2006;73:1009-1015
42. Centers for Disease Control and Prevention. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults <65 years at high risk: a report on recommendations of the task force on community preventative services. MMWR Morb Mortal Wkly Rep 2005;54:RR-5.
43. Mossad SB. Influenza update 2007-2008: vaccine advances, pandemic preparation. Cleve Clin J Med 2007;74:889-894
44. Shenson D, Benson W, Harris A. Expanding the delivery of clinical preventive services through community collaboration: the SPARC model. Prev Chronic Dis 2008;5:1-8.
45. Jha AK, Wright SM, Perlin JB. Performance measures, vaccinations, and pneumonia rates among high-risk patients in veterans administration health care. Am J Public Health 2007;97:2167-2172
46. Byrnes P, Fulton B, Crawford M. An audit of influenza vaccination rates. Aust Fam Physician 2006;35:551-552
47. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121:S28-35.
48. Stinchfield PK. Practice-proven interventions to increase vaccination rates and broaden the immunization season. Am J Med 2008;121:S11-21.
49. Solovy A, Hoppszallern S, Brown SB. The 2007 most wired results: ten lessons from the top 100. Hosp Health Netw 2007;81:40-55.
50. Ayoub WT, Newman ED, Blosky MA, Sterwart WF, Wood GC. Improving detection and treatment of osteoporosis: redesigning care using the electronic medical record and shared medical appointments. Osteoporos Int 2009;20:37-42.